Security key
29772L108
Eton Pharmaceuticals, Inc. - Common Stock (ETON)
CUSIP: 29772L108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 8,228,308
- Total 13F value
- $27,068,977
- Share change
- +1,045,620
- Put/Call ratio
- 2.4%
- SEC-reported price per share
- $3.29
- Number of holders
- 44
- Value change
- +$3,401,849
- Number of buys
- 13
- Number of sells
- 22
- Shares outstanding
- 27,281,304
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
44
Top holders
10
ETON full security history
Ownership snapshot
Full 13F holder table
Eton Pharmaceuticals, Inc. SEC filings
Eton Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ETON - Eton Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 9%
Showing 1-6 of 15 holder rows.
Quick read
Opaleye Management Inc. leads the comparable SEC ownership view at 9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Opaleye Management Inc.'s linked filing trail.
Comparable ownership
Top 5
Opaleye Management Inc.
9%
VANGUARD GROUP INC
3.8%
Acuitas Investments, LLC
2.1%
Westside Investment Management, Inc.
2.1%
National Philanthropic Trust
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
Company
|
9%
|
$9,171,679
2,445,781 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.8%
|
$3,853,830
1,027,688 shares
|
— | 31 Mar 2024 |
| Acuitas Investments, LLC |
13F
Company
|
2.1%
|
$2,174,850
579,960 shares
|
— | 31 Mar 2024 |
| Westside Investment Management, Inc. |
13F
Company
|
2.1%
|
$2,152,357
573,960 shares
|
— | 31 Mar 2024 |
| National Philanthropic Trust |
13F
Company
|
1.8%
|
$1,845,420
492,112 shares
|
— | 31 Mar 2024 |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
Company
|
1.1%
|
$1,125,000
300,000 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
8,228,308
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
43
Q2 2024 holders
44
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|